🚀 VC round data is live in beta, check it out!
Asymchem Laboratories Valuation Multiples
Discover revenue and EBITDA valuation multiples for Asymchem Laboratories and similar public comparables like Avantor, Laurus Labs, Laboratorios Rovi, Hangzhou Tigermed and more.
Asymchem Laboratories Overview
About Asymchem Laboratories
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Founded
1998
HQ
Employees
9.6K
Website
Financials (LTM)
EV
$5B
Asymchem Laboratories Financials
Asymchem Laboratories reported last 12-month revenue of $1B and EBITDA of $273M.
In the same LTM period, Asymchem Laboratories generated $438M in gross profit, $273M in EBITDA, and $176M in net income.
Revenue (LTM)
Asymchem Laboratories P&L
In the most recent fiscal year, Asymchem Laboratories reported revenue of $978M and EBITDA of $271M.
Asymchem Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $978M | XXX | XXX | XXX |
| Gross Profit | $438M | XXX | $411M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 42% | XXX | XXX | XXX |
| EBITDA | $273M | XXX | $271M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $176M | XXX | $166M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 17% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Asymchem Laboratories Stock Performance
Asymchem Laboratories has current market cap of $6B, and enterprise value of $5B.
Market Cap Evolution
Asymchem Laboratories' stock price is $16.45.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $6B | -2.6% | XXX | XXX | XXX | $0.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAsymchem Laboratories Valuation Multiples
Asymchem Laboratories trades at 4.8x EV/Revenue multiple, and 17.9x EV/EBITDA.
EV / Revenue (LTM)
Asymchem Laboratories Financial Valuation Multiples
As of April 19, 2026, Asymchem Laboratories has market cap of $6B and EV of $5B.
Equity research analysts estimate Asymchem Laboratories' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Asymchem Laboratories has a P/E ratio of 33.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 4.8x | XXX | 5.0x | XXX | XXX | XXX |
| EV/EBITDA | 17.9x | XXX | 18.0x | XXX | XXX | XXX |
| EV/EBIT | 25.0x | XXX | 26.6x | XXX | XXX | XXX |
| EV/Gross Profit | 11.2x | XXX | 11.9x | XXX | XXX | XXX |
| P/E | 33.8x | XXX | 35.7x | XXX | XXX | XXX |
| EV/FCF | 420.8x | XXX | 243.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Asymchem Laboratories Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Asymchem Laboratories Margins & Growth Rates
Asymchem Laboratories' revenue in the last 12 month grew by 21%.
Asymchem Laboratories' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Asymchem Laboratories' rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Asymchem Laboratories' rule of X is 77% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Asymchem Laboratories Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 47% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 77% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 11% | XXX | 11% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Asymchem Laboratories Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Asymchem Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantor | XXX | XXX | XXX | XXX | XXX | XXX |
| Laurus Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Laboratorios Rovi | XXX | XXX | XXX | XXX | XXX | XXX |
| Hangzhou Tigermed | XXX | XXX | XXX | XXX | XXX | XXX |
| Siegfried | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Asymchem Laboratories M&A Activity
Asymchem Laboratories acquired XXX companies to date.
Last acquisition by Asymchem Laboratories was on XXXXXXXX, XXXXX. Asymchem Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Asymchem Laboratories
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAsymchem Laboratories Investment Activity
Asymchem Laboratories invested in XXX companies to date.
Asymchem Laboratories made its latest investment on XXXXXXXX, XXXXX. Asymchem Laboratories invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Asymchem Laboratories
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Asymchem Laboratories
| When was Asymchem Laboratories founded? | Asymchem Laboratories was founded in 1998. |
| Where is Asymchem Laboratories headquartered? | Asymchem Laboratories is headquartered in China. |
| How many employees does Asymchem Laboratories have? | As of today, Asymchem Laboratories has over 9K employees. |
| Who is the CEO of Asymchem Laboratories? | Asymchem Laboratories' CEO is Hao Hong. |
| Is Asymchem Laboratories publicly listed? | Yes, Asymchem Laboratories is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Asymchem Laboratories? | Asymchem Laboratories trades under 002821 ticker. |
| When did Asymchem Laboratories go public? | Asymchem Laboratories went public in 2016. |
| Who are competitors of Asymchem Laboratories? | Asymchem Laboratories main competitors are Avantor, Laurus Labs, Laboratorios Rovi, Hangzhou Tigermed. |
| What is the current market cap of Asymchem Laboratories? | Asymchem Laboratories' current market cap is $6B. |
| What is the current revenue of Asymchem Laboratories? | Asymchem Laboratories' last 12 months revenue is $1B. |
| What is the current revenue growth of Asymchem Laboratories? | Asymchem Laboratories revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Asymchem Laboratories? | Current revenue multiple of Asymchem Laboratories is 4.8x. |
| Is Asymchem Laboratories profitable? | Yes, Asymchem Laboratories is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Asymchem Laboratories? | Asymchem Laboratories' last 12 months EBITDA is $273M. |
| What is Asymchem Laboratories' EBITDA margin? | Asymchem Laboratories' last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Asymchem Laboratories? | Current EBITDA multiple of Asymchem Laboratories is 17.9x. |
| What is the current FCF of Asymchem Laboratories? | Asymchem Laboratories' last 12 months FCF is $12M. |
| What is Asymchem Laboratories' FCF margin? | Asymchem Laboratories' last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Asymchem Laboratories? | Current FCF multiple of Asymchem Laboratories is 420.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.